Literature DB >> 1534094

Increased radiosensitivity of cell lines derived from a Down's syndrome patient with ocular telangiectasia.

M A Hannan1, M Waghray, D Sigut, P T Ozand.   

Abstract

Studies on radiosensitivity of cells from Down's syndrome (DS) patients were stimulated by the observation of their increased susceptibility to leukemia. While lymphocytes from DS patients were found to consistently show increased chromosomal aberrations after exposure to ionizing radiation, conflicting reports have been published on the radiosensitivity of fibroblasts and lymphoblastoid cell lines (LCL) derived from these patients. In the present study, cultured skin fibroblast lines developed from a DS patient with ocular telangiectasia and five normal subjects were compared for both cell killing and chromosomal aberrations (breaks, translocations, inversions, dicentrics, and rings) after low dose-rate gamma-irradiation. The LCLs developed from the patient and two normal persons were also compared for chromosomal radiosensitivity using the same irradiation protocol. A comparison of the D10 (radiation dose resulting in 10% survival) values estimated from the survival curves and the frequencies of induced chromosome aberrations in different cell lines showed that the DS cells were more radiosensitive than the respective controls. The increased cellular radiosensitivity of the DS patient reported here could be due to a combination of genetic factors (DS plus a gene for hypersensitivity to radiation) and, thus, may not be representative of all DS patients. Alternatively, the use of low dose-rate irradiation could be a factor in revealing the radiosensitivity of DS fibroblasts in general.

Entities:  

Mesh:

Year:  1992        PMID: 1534094     DOI: 10.1177/08830738920070011311

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  1 in total

1.  Leukemia Risk in a Cohort of 3.9 Million Children with and without Down Syndrome.

Authors:  Emily C Marlow; Jonathan Ducore; Marilyn L Kwan; Stephanie Y Cheng; Erin J A Bowles; Robert T Greenlee; Jason D Pole; Alanna Kulchak Rahm; Natasha K Stout; Sheila Weinmann; Rebecca Smith-Bindman; Diana L Miglioretti
Journal:  J Pediatr       Date:  2021-03-06       Impact factor: 6.314

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.